Keywords: Parkinson's Disease, Neurodegeneration, Depression
Arterial spin labeling-magnetic resonance imaging (ASL-MRI) combined with inline T1-weighted-based brain morphometry was used to evaluate regional cerebral blood flow in this study, which explored alteration of cerebral perfusion in Parkinson’s disease (PD) patients with depression and investigated its underlying neural mechanism. The results showed decreased cerebral perfusion in several brain regions in PD patients compared to healthy controls and a correlation between decreased cerebral perfusion of the right occipital white matter and right cingulate gyrus in PD patients with depression. This finding suggested that hypoperfusion of the limbic system is involved in the pathogenesis of PD with depression.1. Tsai WC, Lin HC, Chang CC, et al. Neuropsychiatric symptoms in Parkinson's disease: association with caregiver distress and disease severity. Int Psychogeriatr Jun 2020;32(6):733-739.
2. Jones JD, Kurniadi NE, Kuhn TP, et al. Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort. Neuropsychology Nov 2019;33(8):1111-1120.
3. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48(8):813-829.
4. Starkstein S, Dragovic M, Jorge R, et al. Diagnostic criteria for depression in Parkinson's disease: a study of symptom patterns using latent class analysis. Mov Disord Oct 2011;26(12):2239-2245.
5. Buxton RB, Frank LR, Wong EC, et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med Sep 1998;40(3):383-396.
6. Schmitter D, Roche A, Maréchal B, et al. An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease. Neuroimage Clin 2015;7:7-17.
7. Lin WC, Chen PC, Huang CC, et al. Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson's Disease. Front Neurol 2017;8:246.
8. Imamura K, Okayasu N, Nagatsu T. The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment. Acta Neurol Scand Jul 2011;124(1):28-39.
9. Kim YD, Jeong HS, Song IU, et al. Brain perfusion alterations in depressed patients with Parkinson's disease. Ann Nucl Med Dec 2016;30(10):731-737.
Table 1. Demographics and clinical data under study. Data conforming to a normal distribution are expressed as x±s, and non-conformities are denoted by M (Q1, Q3). NC: normal control; PD: Parkinson' s disease;PD-n: Parkinson' s disease without depression; PD-d: Parkinson's disease with depression; ①: Chi-Squared tests; ②: Independent samples t-tests; ③: Mann-Whitney U test.
Table 2. Correlation analysis between the regional brain CBF value with significant perfusion differences and HAMD scale scores. *: There was statistically significant correlation with the HAMD scores through partial correlation analysis; HAMD: Hamilton Depression Rating Scale; LTc: CBF of left thalamus; LHc: CBF of left hippocampus; RPGc: CBF of right parietal gray matter; LOWc: CBF of left occipital white matter ROWc: CBF of right occipital white matter; RCc: CBF of right cingulate gyrus.
Figure 1. Schematic diagram of brain segmentation, with the images of a healthy subject's left thalamus as an example (female; 67 years old). (1A) Results of brain segmentation; (1B) Fused brain segmentation results onto 3D T1WI images.
Figure 2. Boxplots of the CBF value in brain regions with significant perfusion differences. (2A) NC group vs. PD group; (2B) PD-n group vs. PD-d group.
Figure 3. Representative axial slices of the brain cerebral blood flow images for (3A) a healthy subject (female; 67 years old), (3B) a typical PD-n group subject (male; 64 years old), (3C) a typical PD-d group subject (male; 75 years old). It is possible that (3B) and (3C) had decreased CBF in several brain regions compared to (3A); (3C) had decreased CBF in the occipital lobe and cingulate gyrus compared to (3B).